Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1Gastrointestinal 1Classical hematology 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Lymphoma, Non-Hodgkin 1Fanconi Anemia 1Colorectal Neoplasms 1Anus Neoplasms 1

Interventions

pembrolizumab 7Nivolumab 3poly ICLC 2durvalumab 2Rituximab 2Gemcitabine 2Capecitabine 2utomilumab 1tremelimumab 1tanespimycin 1mirabegron 1entinostat 1ciforadenant 1cemiplimab 1Vorinostat 1Thalidomide 1Specimen Handling 1SUB1 protein, human 1SRA737 1Ritonavir 1Radiotherapy 1Radiation 1Polymerase Chain Reaction 1Paclitaxel 1Nicotine 1Microarray Analysis 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Injections, Subcutaneous 1Indinavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × SRA737 × Lymphoid × Clear all
NCT02797964 2023-06-18

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Sierra Oncology LLC - a GSK company

Phase 1/2 Completed
107 enrolled 20 charts
Classical hematologyGastrointestinalHead & NeckLymphoid

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Fanconi Anemia, Lymphoma, Non-Hodgkin, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡